Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
AC Immune SA
AC Immune SA
(ACIU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fluorodopa f-18
schizophrenia
,
alzheimer disease
,
triple negative breast neoplasms
,
non-small-cell lung carcinoma
,
non-hodgkin lymphoma
,
large b-cell lymphoma diffuse
,
recurrence
,
multiple sclerosis
,
chronic progressive multiple sclerosis
,
cognitive dysfunction
,
pick disease of the brain
,
healthy volunteers/patients
,
disease
,
dementia
,
frontotemporal dementia
,
progressive supranuclear palsy
,
neoplasms
,
cardiotoxicity
,
carotid artery diseases
,
atherosclerosis
Gilvetmab
urinary bladder neoplasms
,
glandular and epithelial neoplasms
,
myoepithelioma
,
hepatitis c
,
hepatitis
,
hepatitis a
,
multiple myeloma
,
neoplasms by histologic type
,
urinary bladder diseases
,
astrocytoma
,
myeloid leukemia acute
,
gata2 deficiency
,
pancreatic neoplasms
,
colorectal neoplasms
,
glioblastoma
,
colonic neoplasms
,
cutaneous malignant melanoma
,
adenocarcinoma
,
prostatic neoplasms
,
glioma
,
transitional cell carcinoma
,
liver neoplasms
,
small cell lung carcinoma
,
carcinoma
,
pancreatic ductal carcinoma
,
squamous cell carcinoma
,
urologic neoplasms
,
stomach neoplasms
,
endometrial neoplasms
,
recurrence
,
neoplasms by site
,
rectal neoplasms
,
ovarian neoplasms
,
chordoma
,
biliary tract neoplasms
,
hepatocellular carcinoma
,
sarcoma
,
microsatellite instability
,
gliosarcoma
,
non-hodgkin lymphoma
,
hodgkin disease
,
uterine cervical neoplasms
,
follicular lymphoma
,
lymphoma
,
squamous cell neoplasms
,
female genital neoplasms
,
endometrioid carcinoma
,
spinocerebellar degenerations
,
neuroendocrine tumors
,
gastrointestinal neoplasms
,
adenocarcinoma of lung
,
basal cell carcinoma
,
basal cell neoplasms
,
nose neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
t-cell lymphoma peripheral
,
oropharyngeal neoplasms
,
prostatic diseases
,
cholangiocarcinoma
,
diffuse intrinsic pontine glioma
,
hematologic neoplasms
,
b-cell chronic lymphocytic leukemia
,
bile duct neoplasms
,
genetic therapy
,
smoldering multiple myeloma
,
carcinosarcoma
,
urogenital neoplasms
,
small cell carcinoma
,
penile neoplasms
,
adrenocortical carcinoma
,
mesothelioma
,
drug-related side effects and adverse reactions
,
lung diseases
,
precancerous conditions
,
bronchopulmonary dysplasia
,
tobacco smoking
,
b-cell lymphoma marginal zone
,
mantle-cell lymphoma
,
waldenstrom macroglobulinemia
,
large b-cell lymphoma diffuse
,
burkitt lymphoma
,
oligodendroglioma
,
merkel cell carcinoma
,
hereditary nonpolyposis colorectal neoplasms
,
b-cell lymphoma
,
disease
,
melanoma
,
non-small-cell lung carcinoma
,
neoplasms
,
neoplasm metastasis
,
squamous cell carcinoma of head and neck
,
renal cell carcinoma
,
lung neoplasms
,
breast neoplasms
,
head and neck neoplasms
,
brain neoplasms
,
skin neoplasms
,
kidney neoplasms
,
triple negative breast neoplasms
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
pathologic complete response
Bevifimod
clostridium infections
Fludeoxyglucose f-18
mantle-cell lymphoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use